DOI QR코드

DOI QR Code

The Efficacy and Safety of Platelet-Rich Plasma and Adipose-Derived Stem Cells: An Update

  • Choi, Jaehoon (Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Minn, Kyung Won (Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Chang, Hak (Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
  • Received : 2012.01.30
  • Accepted : 2012.02.09
  • Published : 2012.11.15

Abstract

During the past decade, many studies using platelet-rich plasma (PRP) or adipose-derived stem cells (ASCs) have been conducted in various medical fields, from cardiovascular research to applications for corneal diseases. Nonetheless, there are several limitations of practical applications of PRP and ASCs. Most reports of PRP are anecdotal and few include controls to determine the specific role of PRP. There is little consensus regarding PRP production and characterization. Some have reported the development of an antibody to bovine thrombin, which was the initiator of platelet activation. In the case of ASCs, good manufacturing practices are needed for the production of clinical-grade human stem cells, and in vitro expansion of ASCs requires approval of the Korea Food and Drug Administration, such that considerable expense and time are required. Additionally, some have reported that ASCs could have a potential risk of transformation to malignant cells. Therefore, the authors tried to investigate the latest research on the efficacy and safety of PRP and ASCs and report on the current state and regulation of these stem cell-based therapies.

Keywords

References

  1. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004;62:489-96. https://doi.org/10.1016/j.joms.2003.12.003
  2. Eppley BL, Pietrzak WS, Blanton M. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg 2006;118:147e-159e. https://doi.org/10.1097/01.prs.0000239606.92676.cf
  3. Muehlberg FL, Song YH, Krohn A, et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 2009;30:589-97. https://doi.org/10.1093/carcin/bgp036
  4. Yu JM, Jun ES, Bae YC, et al. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev 2008;17:463-73. https://doi.org/10.1089/scd.2007.0181
  5. Donnenberg VS, Zimmerlin L, Rubin JP, et al. Regenerative therapy after cancer: what are the risks? Tissue Eng Part B Rev 2010;16:567-75. https://doi.org/10.1089/ten.teb.2010.0352
  6. Zimmerlin L, Donnenberg AD, Rubin JP, et al. Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A 2011;17:93-106.
  7. Jotzu C, Alt E, Welte G, et al. Adipose tissue-derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor-derived factors. Anal Cell Pathol (Amst) 2010;33:61-79. https://doi.org/10.1155/2010/695162
  8. Zhao M, Dumur CI, Holt SE, et al. Multipotent adipose stromal cells and breast cancer development: Think globally, act locally. Mol Carcinog 2010;49:923-7. https://doi.org/10.1002/mc.20675
  9. Prantl L, Muehlberg F, Navone NM, et al. Adipose tissuederived stem cells promote prostate tumor growth. Prostate 2010;70:1709-15. https://doi.org/10.1002/pros.21206
  10. Hu Z, Peel SA, Ho SK, et al. Platelet-rich plasma induces mRNA expression of VEGF and PDGF in rat bone marrow stromal cell differentiation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;107:43-8. https://doi.org/10.1016/j.tripleo.2008.06.023
  11. Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7:393-5. https://doi.org/10.1080/14653240500319234
  12. Hausman GJ, Richardson RL. Adipose tissue angiogenesis. J Anim Sci 2004;82:925-34. https://doi.org/10.2527/2004.823925x
  13. Kevy S, Jacobson M, Benoit P. The biology of platelet concentrate as prepared by the Harvest Technologies Smart- PReP System. Proceedings of the 3rd Annual Meeting of Techvest Conference on Tissue Repair, Replacement, and Regeneration; 2001 Oct 23; New York, USA.
  14. Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85: 638-46. https://doi.org/10.1016/S1079-2104(98)90029-4
  15. Slater M, Patava J, Kingham K, et al. Involvement of platelets in stimulating osteogenic activity. J Orthop Res 1995;13: 655-63. https://doi.org/10.1002/jor.1100130504
  16. Zimmermann R, Arnold D, Strasser E, et al. Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates. Vox Sang 2003;85:283-9. https://doi.org/10.1111/j.0042-9007.2003.00361.x
  17. Kevy SV, Jacobson MS. Comparison of methods for point of care preparation of autologous platelet gel. J Extra Corpor Technol 2004;36:28-35.
  18. Gonshor A. Technique for producing platelet-rich plasma and platelet concentrate: background and process. Int J Periodontics Restorative Dent 2002;22:547-57.
  19. Jameson CA. Autologous platelet concentrate for the production of platelet gel. Lab Med 2007;38:39-42. https://doi.org/10.1309/3UA5HWYVKNCE01AR
  20. Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev 1993;7:52-62. https://doi.org/10.1016/0268-960X(93)90024-X
  21. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 2004;114: 1502-8.
  22. Christie RJ, Carrington L, Alving B. Postoperative bleeding induced by topical bovine thrombin: report of two cases. Surgery 1997;121:708-10. https://doi.org/10.1016/S0039-6060(97)90061-1
  23. Rapaport SI, Zivelin A, Minow RA, et al. Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin. Am J Clin Pathol 1992;97:84-91. https://doi.org/10.1093/ajcp/97.1.84
  24. Zehnder JL, Leung LL. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. Blood 1990;76:2011-6.
  25. Sen A, Lea-Currie YR, Sujkowska D, et al. Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J Cell Biochem 2001;81:312-9. https://doi.org/10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q
  26. Yoshimura K, Sato K, Aoi N, et al. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg 2008;32:48-55. https://doi.org/10.1007/s00266-007-9019-4
  27. Yoshimura K, Sato K, Aoi N, et al. Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adiposederived stem cells. Dermatol Surg 2008;34:1178-85. https://doi.org/10.1111/j.1524-4725.2008.34256.x
  28. Rigotti G, Marchi A, Galie M, et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg 2007;119:1409-22. https://doi.org/10.1097/01.prs.0000256047.47909.71
  29. Wislet-Gendebien S, Leprince P, Moonen G, et al. Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells. J Cell Sci 2003;116:3295-302. https://doi.org/10.1242/jcs.00639
  30. Bonab MM, Alimoghaddam K, Talebian F, et al. Aging of mesenchymal stem cell in vitro. BMC Cell Biol 2006;7:14. https://doi.org/10.1186/1471-2121-7-14
  31. Briquet A, Dubois S, Bekaert S, et al. Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCIDrepopulating cells and committed progenitor cells of B lymphoid and myeloid lineages. Haematologica 2010;95:47-56. https://doi.org/10.3324/haematol.2009.008524
  32. Rubio D, Garcia-Castro J, Martin MC, et al. Spontaneous human adult stem cell transformation. Cancer Res 2005;65: 3035-9.
  33. Rubio D, Garcia S, De la Cueva T, et al. Human mesenchymal stem cell transformation is associated with a mesenchymal-epithelial transition. Exp Cell Res 2008;314:691-8. https://doi.org/10.1016/j.yexcr.2007.11.017
  34. de la Fuente R, Bernad A, Garcia-Castro J, et al. Retraction: Spontaneous human adult stem cell transformation. Cancer Res 2010;70:6682. https://doi.org/10.1158/0008-5472.CAN-10-2451
  35. Garcia S, Bernad A, Martin MC, et al. Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Exp Cell Res 2010;316:1648-50. https://doi.org/10.1016/j.yexcr.2010.02.016
  36. Herrera B, Inman GJ. A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum. BMC Cell Biol 2009;10:20. https://doi.org/10.1186/1471-2121-10-20
  37. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-41 https://doi.org/10.1016/S0140-6736(04)16104-7
  38. Bang OY, Lee JS, Lee PH, et al. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005; 57:874-82. https://doi.org/10.1002/ana.20501
  39. Klein R, Dumble LJ. Transmission of Creutzfeldt-Jakob disease by blood transfusion. Lancet 1993;341:768.
  40. Kievits F, Boerenkamp WJ, Ivanyi P. H-2-dependent binding of xenogeneic beta 2-microglobulin from culture media. J Immunol 1988;140:4253-5.
  41. Mackensen A, Drager R, Schlesier M, et al. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol Immunother 2000;49:152-6. https://doi.org/10.1007/s002620050614
  42. Selvaggi TA, Walker RE, Fleisher TA. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 1997;89:776-9.
  43. Shahdadfar A, Fronsdal K, Haug T, et al. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 2005;23:1357-66. https://doi.org/10.1634/stemcells.2005-0094
  44. Shigeno Y, Ashton BA. Human bone-cell proliferation in vitro decreases with human donor age. J Bone Joint Surg Br 1995;77:139-42.
  45. Yamamoto N, Isobe M, Negishi A, et al. Effects of autologous serum on osteoblastic differentiation in human bone marrow cells. J Med Dent Sci 2003;50:63-9.
  46. Williams SK, McKenney S, Jarrell BE. Collagenase lot selection and purification for adipose tissue digestion. Cell Transplant 1995;4:281-9. https://doi.org/10.1016/0963-6897(95)00006-J
  47. Kucerova L, Altanerova V, Matuskova M, et al. Adipose tissuederived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 2007;67:6304-13. https://doi.org/10.1158/0008-5472.CAN-06-4024
  48. Cousin B, Ravet E, Poglio S, et al. Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS One 2009;4:e6278. https://doi.org/10.1371/journal.pone.0006278
  49. Harvath L. Food and Drug Administration's proposed approach to regulation of hematopoietic stem/progenitor cell products for therapeutic use. Transfus Med Rev 2000;14:104-11. https://doi.org/10.1016/S0887-7963(00)80002-4
  50. European Medicines Agency. DIRECTIVE 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use [Internet]. Lodon: The European Parliament and of the Council of the Community; c2012 [cited 2012 Jan 30]. Available from: http://www.emea.europa.eu/pdfs/human/pmf/2001-83-EC.pdf.
  51. European Medicines Agency. Guideline on human cell-based medicinal products [Internet]. Lodon: The European Parliament and of the Council of the Community; c2012 [cited 2012 Jan 30]. Available from: http:// www.emea.europa. eu/pdfs/human/cpwp/41086906enfin.pdf.
  52. Rehmann W, Morgan G. The regulation of advanced therapies: perspectives from the EU [Internet]. Lodon: Taylor Wessing; c2012 [cited 2012 Jan 30]. Available from: http:// www.taylorwessing.com/uploads/tx_siruplawyermanagement/ The_Regulation_of_Advanced_Therapies.pdf.
  53. Halme DG, Kessler DA. FDA regulation of stem-cell-based therapies. N Engl J Med 2006;355:1730-5. https://doi.org/10.1056/NEJMhpr063086
  54. Kim M, Kim I, Lee SK, et al. Clinical trial of autologous differentiated adipocytes from stem cells derived from human adipose tissue. Dermatol Surg 2011;37:750-9. https://doi.org/10.1111/j.1524-4725.2011.01765.x

Cited by

  1. Evidenzbasierte Evaluation intraoperativer biologischer Augmentation und deren Komplikationspotenzial vol.26, pp.2, 2012, https://doi.org/10.1007/s00142-012-0740-x
  2. Results and long-term patient satisfaction after gluteal augmentation with platelet-rich plasma-enriched autologous fat vol.36, pp.12, 2013, https://doi.org/10.1007/s00238-013-0887-3
  3. The Effect of Platelet-Rich Plasma on Composite Graft Survival vol.134, pp.2, 2014, https://doi.org/10.1097/prs.0000000000000392
  4. Cell Therapy for Wound Healing vol.29, pp.3, 2012, https://doi.org/10.3346/jkms.2014.29.3.311
  5. Clinical Application of Adipose Stem Cells in Plastic Surgery vol.29, pp.4, 2014, https://doi.org/10.3346/jkms.2014.29.4.462
  6. Stem Cell and Research in Plastic Surgery vol.29, pp.suppl3, 2012, https://doi.org/10.3346/jkms.2014.29.s3.s167
  7. Injectable Tissue-Engineered Soft Tissue for Tissue Augmentation vol.29, pp.suppl3, 2014, https://doi.org/10.3346/jkms.2014.29.s3.s170
  8. Treatment Algorithm of Complications after Filler Injection: Based on Wound Healing Process vol.29, pp.suppl3, 2014, https://doi.org/10.3346/jkms.2014.29.s3.s176
  9. In Vivo Effects of Adipose-Derived Stem Cells in Inducing Neuronal Regeneration in Sprague-Dawley Rats Undergoing Nerve Defect Bridged with Polycaprolactone Nanotubes vol.29, pp.suppl3, 2012, https://doi.org/10.3346/jkms.2014.29.s3.s183
  10. Effects of Platelet-Rich Plasma, Adipose-Derived Stem Cells, and Stromal Vascular Fraction on the Survival of Human Transplanted Adipose Tissue vol.29, pp.suppl3, 2012, https://doi.org/10.3346/jkms.2014.29.s3.s193
  11. Effects of Polydeoxyribonucleotide in the Treatment of Pressure Ulcers vol.29, pp.suppl3, 2012, https://doi.org/10.3346/jkms.2014.29.s3.s222
  12. Effect of Endogenous Bone Marrow Derived Stem Cells Induced by AMD-3100 on Expanded Ischemic Flap vol.29, pp.suppl3, 2014, https://doi.org/10.3346/jkms.2014.29.s3.s237
  13. Recent Advancements in Autologous Fat Grafting vol.20, pp.1, 2012, https://doi.org/10.14730/aaps.2014.20.1.3
  14. The principles of tissue engineering and its recent advances and future prospects vol.57, pp.2, 2012, https://doi.org/10.5124/jkma.2014.57.2.145
  15. Platelet-Rich Plasma and Adipose-Derived Mesenchymal Stem Cells for Regenerative Medicine-Associated Treatments in Bottlenose Dolphins ( Tursiops truncatus ) vol.9, pp.9, 2014, https://doi.org/10.1371/journal.pone.0108439
  16. Problems Associated with Alloplastic Materials in Rhinoplasty vol.55, pp.6, 2012, https://doi.org/10.3349/ymj.2014.55.6.1617
  17. The biomechanical and histological effects of platelet-rich plasma on fracture healing vol.23, pp.5, 2015, https://doi.org/10.1007/s00167-013-2734-2
  18. Effects of Human Adipose-Derived Stem Cells and Stromal Vascular Fraction on Cryopreserved Fat Transfer vol.41, pp.5, 2012, https://doi.org/10.1097/dss.0000000000000342
  19. Correction of Severely Contracted Nose vol.138, pp.3, 2012, https://doi.org/10.1097/prs.0000000000002516
  20. The Fountain of Youth: A Tale of Parabiosis, Stem Cells, and Rejuvenation vol.12, pp.1, 2017, https://doi.org/10.1515/med-2017-0053
  21. The Effects of Platelet-Rich Plasma and Adipose-Derived Stem Cells on Neovascularization and Fat Graft Survival vol.42, pp.1, 2012, https://doi.org/10.1007/s00266-017-1062-1
  22. Platelet-rich plasma decreases fibroblastic activity and woven bone formation with no significant immunohistochemical effect on long-bone healing: An experimental animal study with radiological outcom vol.26, pp.3, 2012, https://doi.org/10.1177/2309499018802491
  23. Adipose‐derived stem cells for wound healing vol.234, pp.6, 2012, https://doi.org/10.1002/jcp.27922
  24. Stem Cell Injections for Musculoskeletal Pathology: An Overview for the Sports Medicine Professional vol.41, pp.6, 2019, https://doi.org/10.1519/ssc.0000000000000500
  25. The use of stromal vascular fraction (SVF), platelet-rich plasma (PRP) and stem cells in the treatment of osteoarthritis: an overview of clinical trials vol.47, pp.1, 2012, https://doi.org/10.1080/21691401.2019.1576710
  26. Novel Approaches in Addressing Ovarian Insufficiency in 2019: Are We There Yet? vol.29, pp.None, 2012, https://doi.org/10.1177/0963689720926154
  27. Platelet-Rich Plasma Enhances Distal Flap Viability and Underlying Vascularity in a Radiated Rotational Flap Rodent Model vol.22, pp.3, 2012, https://doi.org/10.1089/fpsam.2019.0018
  28. Combination of platelet-rich plasma and stromal vascular fraction on the level of transforming growth factor-β in rat subjects experiencing deep dermal burn injury vol.60, pp.None, 2012, https://doi.org/10.1016/j.amsu.2020.11.088
  29. Allogeneic Platelet-Rich Plasma: Is It Safe and Effective for Wound Repair? vol.62, pp.1, 2012, https://doi.org/10.1159/000514223
  30. Evidence-based indications of platelet-rich plasma therapy vol.14, pp.1, 2012, https://doi.org/10.1080/17474086.2021.1860002